缺乏品牌与专利的中国药企如何在国际市场站稳脚跟?上海医药集团以原料药跨国代加工为突破口,频频叩开欧美大门,目前已与十多家跨国药企建立合作关系。全球医药行业90%以上的利润在欧美。中国制药要做大做强必须进入欧美,可一无专利二无品牌,美国食品药品监督管理局(FDA)认证和 How do Chinese pharmaceutical companies lacking brands and patents gain a firm foothold in the international market? Shanghai Pharmaceutical Group takes the cross-country processing of APIs as the breakthrough point and frequently opens the door to Europe and the United States. At present, it has established cooperative relationships with more than 10 multinational pharmaceutical companies. More than 90% of global pharmaceutical industry profits in Europe and the United States. China Pharmaceutical to become bigger and stronger must enter Europe and the United States, there is no patent No two brands, the United States Food and Drug Administration (FDA) certification and